our leadership & governance 

Our management team collectively has decades of experience from leading key functions at large biotechnology and pharmaceutical companies, including supporting the development and launch of more than 25 new medicines over the last twenty years. Many of us were heavily involved in, or led, the launch of modern anti-seizure medicines, so we are deeply familiar with the therapeutic area and the significant unmet medical need that remains.

Together we share a passion to serve children and adults with epilepsies and brain conditions. 

leadership team


Jeremy M. Levin, D.Phil, MB BChir

Chief Executive Officer and Chairman


Meg Alexander

Chief Strategy Officer


Zhong Zhong, Ph.D.

Chief Scientific Officer


Jeffrey Rona

Chief Business and Financial Officer


Julia Tsai, Ph.D.

Senior Vice President of Clinical Development